| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.00028 | 1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00024 | 1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.00023 | 1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.00021 | 1 |